Fresenius a “Top Performer” in its Sector
Fresenius Medical Care is a leader in the MedTech sector, with a “Buy” rating from Zacks. An international company with a diversified product range, both revenue and net income to shareholders is expected to rise.
Read the full article » | Posted 04-12-2018
Related Articles
- Nephrologist Dr. Roberto Collazo Shares New Treatments for Kidney Disease and ESKD Posted 12-11-2024
- Ellen Lukens from CMMI Presents on the Kidney Care Choices Model Posted 12-11-2024
- 2025 NKF Survey on Kidney Health Priorities Finds Home Dialysis is a Patient Priority Posted 12-11-2024
- FDA Correction on Baxter MiniCap Extended Life PD Transfer Set Posted 12-11-2024